zacks
cancer

Monitor the latest movements within the BeiGene Ltd real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BGNE quote. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

chronic lymphocytic leukemia

During the month of April, Beigene Ltd ’s stock price has reached a high of $242.44 and a low of $210.32. The other risk for BeiGene is whether the stock might be delisted if U.S. regulators find the company hasn’t been forthcoming in its accounting practices, a common concern among Chinese companies. In the long term, however, the stock has potential, with more than 60 clinical programs in its pipeline.

Immunocore (IMCR) to Report Q4 Earnings: What’s in the Cards?

J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023 In the investing world, the art of “stock picking” is crucial for success; investors must choose the right… Enlivex, BeiGene collaborate to evaluate Allocetra with Tislelizumab Enlivex Therapeutics announced a clinical collaboration with BeiGene . One simple way to benefit from the stock market is to buy an index fund. Below are the latest news stories about BEIGENE LTD that investors may wish to consider to help them evaluate BGNE as an investment opportunity.

Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. One share of BGNE stock can currently be purchased for approximately $238.45.

shares outstanding

An indication of interest to purchase securities involves no obligation or commitment of any kind. Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here.

BeiGene Stock Earnings

In the Morningstar Style Box, large-gig economy: every little thing you have to learn about this labor market names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Investing.com – BeiGene reported on Thursday second quarter erl ||earnings that beat analysts’ forecasts and revenue that topped expectations. Investing.com – BeiGene reported on Thursday third quarter erl ||earnings that missed analysts’ forecasts and revenue that topped expectations. Investing.com – BeiGene reported on Thursday fourth quarter erl ||earnings that missed analysts’ forecasts and revenue that fell short of expectations. Investing.com – BeiGene reported on Thursday first quarter erl ||earnings that beat analysts’ forecasts and revenue that topped expectations. Investing.com – BeiGene reported on Thursday third quarter erl ||earnings that beat analysts’ forecasts and revenue that topped expectations.

Based on an average daily trading volume, of 244,200 shares, the days-to-cover ratio is currently 8.9 days. Investing.com – BeiGene reported on Thursday second quarter erl ||earnings that missed analysts’ forecasts and revenue that fell short of expectations. Investing.com – BeiGene ADS reported on Wednesday first quarter erl ||earnings that beat analysts’ forecasts and revenue that fell short of expectations. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision.

beigene ltd ’s

https://1investing.in/, Ltd. is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates… Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades.

First Quarter in U.S. Stock Funds: The Return of Volatility

We recommend investors evaluate other financial metrics to understand its overall valuation. Before we jump into Beigene Ltd ’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background. The price-earnings ratio is a company’s share price to the company’s Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued. Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate.

Will Beigene Ltd (BGNE) Beat the Rest of the Stocks in the Healthcare Sector? – InvestorsObserver

Will Beigene Ltd (BGNE) Beat the Rest of the Stocks in the Healthcare Sector?.

Posted: Thu, 19 Jan 2023 16:38:13 GMT [source]

This news sentiment score is similar to the average news sentiment of Medical companies. According to analysts’ consensus price target of $292.86, BeiGene has a forecasted upside of 22.8% from its current price of $238.45. CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING—-BeiGene, a global biotechnology company, is convening diverse stakeholders to amplify the mental health needs of the cancer communit… A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. According to analysts, BeiGene’s stock has a predicted upside of 29.30% based on their 12-month price targets. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

BeiGene Earnings Perspective: Return On Capital Employed

Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Over the past 49 months, BGNE’s revenue has gone up $1,092,081,000.The table below shows BGNE’s growth in key financial areas . Over the past 87 months, BGNE’s price/sales ratio has gone down 49.9.

They set a “buy” rating and a $308.00 price objective on the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $292.86. BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide.

BeiGene Expects To Finish Construction At $700 Million New Jersey Site In 2024 – Forbes

BeiGene Expects To Finish Construction At $700 Million New Jersey Site In 2024.

Posted: Wed, 22 Mar 2023 07:00:00 GMT [source]

Fiscal 2022 revenue was $1.4 billion, an increase of 97.9%. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. $BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%. The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%. $BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 80%.

A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. There may be delays, omissions, or inaccuracies in the Information. The technique has proven to be very useful for finding positive surprises.

Whether you decide it’s a good time to buy or sell Beigene Ltd ’s stock based on its stock price forecast is ultimately up to you. Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Beigene Ltd by visiting AAII Stock Evaluator. Market cap or market capitalization is the total market value of all of a company’s outstanding shares.

  • Now owns 885 shares of the company’s stock valued at $119,000 after buying an additional 68 shares in the last quarter.
  • It’s calculated by averaging the closing stock price over the previous 50 trading days.
  • Monitor the latest movements within the BeiGene Ltd real time stock price chart below.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market. For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters.

Provides a general description of the business conducted by this company. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. Click the link below and we’ll send you MarketBeat’s list of the 10 best stocks to own in 2023 and why they should be in your portfolio. You can find your newly purchased BeiGene stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, and alternative assets.

The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. Its geographical segments are China, the United States, and the Rest of the world. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 .

id_ID